REPLICEL LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0428 USD | +4.99% |
|
-.--% | -4.89% |
| 04-18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
| 2023 | RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Performance
| 1 day | +4.99% | ||
| 3 months | -0.70% | ||
| 6 months | -41.77% | ||
| Current year | -4.89% | ||
| 1 year | -43.68% | ||
| 3 years | -83.79% | ||
| 5 years | -83.11% | ||
| 10 years | -99.40% |
Volumes
marketsDaily volume
550
Estimated daily volume
550
Record volume 1
429 181
Record volume 2
382 627
Record volume 3
315 643
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
2 784 341
Net sales ()
0
Number of employees
1
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
39.48 %
Free-Float capitalization (USD)
1 038 743
Highs and lows
Current year
0.03
0.07
1 year
0.030.19
3 years
0.030.35
5 years
0.030.47
10 years
0.036.60
Indicators
Moving average 5 days
0.04
Moving average 20 days
0.04
Moving average 50 days
0.05
Moving average 100 days
0.05
Price spread / (MMA5)
+1.32%
Price spread / (MMA20)
-7.09%
Price spread / (MMA50)
+5.29%
Price spread / (MMA100)
+16.49%
RSI 9 days
50.91
RSI 14 days
50.12
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +4.99% | -.--% | -4.89% | -43.68% | 2.78M | ||
| +2.07% | +8.36% | +8.96% | +19.15% | 105B | ||
| +0.23% | +0.91% | -1.43% | +15.80% | 104B | ||
| -1.24% | +2.66% | +4.40% | +1.01% | 22.94B | ||
| +0.52% | +6.32% | -12.15% | -15.80% | 22.34B | ||
| +5.91% | +5.45% | -4.36% | -25.41% | 19.25B | ||
| -2.02% | +1.75% | -39.98% | -35.33% | 17.08B | ||
| +0.15% | +5.65% | -10.04% | -38.77% | 16.96B | ||
| +0.63% | +3.47% | +6.79% | +42.68% | 14.16B | ||
| +2.32% | +3.80% | +38.61% | +6.56% | 12.63B | ||
| +1.60% | +3.58% | +313.59% | +258.83% | 8.49B | ||
| -1.13% | +0.24% | -24.53% | -31.53% | 8.26B | ||
| -2.76% | +0.96% | +8.93% | +49.85% | 7.84B | ||
| -0.09% | +0.19% | +0.35% | +33.30% | 7.73B | ||
| -4.12% | +3.56% | -52.84% | -69.42% | 7.44B | ||
| +2.18% | +8.63% | +5.03% | +33.28% | 7.17B | ||
| Average | +0.58% | +4.04% | +14.78% | +12.53% | ||
| Weighted average by Cap. | +0.82% | +4.39% | +6.42% | +11.98% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -4.81% | ||
| 2023 | -12.45% | ||
| 2022 | -71.65% | ||
| 2021 | +6.58% | ||
| 2020 | -22.58% | ||
| 2019 | -17.03% | ||
| 2018 | -14.58% | ||
| 2017 | -56.34% | ||
| 2016 | -63.21% | ||
| 2015 | -40.43% | ||
| 2014 | -34.55% | ||
| 2013 | +7.61% | ||
| 2012 | -80.43% | ||
| 2011 | +34.29% | ||
| 2010 | +12.90% |
- Stock Market
- Equities
- REPCF Stock
- Quotes RepliCel Life Sciences Inc.
